EgyptTaevas Global guides medical devices manufacturers through Egypt's EDA registration framework, turning complex regulatory requirements into a clear, executable market entry path. Reduce approval timelines and launch with confidence in one of Africa's larg
Our six interconnected service pillars cover every dimension of EDA product registration, from regulatory strategy through post-market obligations, giving medical devices companies a complete foundation for sustainable market entry in Egypt.
We evaluate your device classification under Egypt's EDA framework and identify the correct registration pathway before a single document is prepared. This upfront analysis prevents costly reclassification delays and aligns your dossier strategy with current EDA expectations. Our team monitors EDA guidance updates to ensure your pathway remains current throughout the process.
Our four-stage engagement process moves your medical device from initial regulatory scoping to active EDA registration management, with clear milestones and transparent communication at every phase.
We begin with a structured intake session to understand your device, its intended use, existing certifications, and target launch timeline. Our regulatory team performs an initial EDA classification review and identifies the applicable registration pathway. You receive a scoping report outlining the regulatory route, estimated timeline, and documentation requirements.
This phase includes a review of your existing technical documentation such as CE Mark technical file or FDA 510(k) clearance letter, identification of any Egypt-specific requirements that differ from your home market approval, and a preliminary gap analysis. We also confirm whether your device category requires local clinical data or performance testing in Egypt. The output is a clear regulatory roadmap that your internal team and leadership can act on immediately.
The Egyptian Drug Authority, established under Law No. 151 of 2019, serves as the single competent authority for medical device registration in Egypt. All medical devices must be registered with EDA before they can be legally imported, distributed, or sold. EDA's medical devices department applies a four-class risk-based classification system aligned with GHTF principles, making prior CE Mark or FDA clearance a significant advantage in the dossier process.
Egypt has progressively strengthened its medical device regulatory framework, with EDA issuing updated technical guidance and expanding its online submission portal to improve transparency and reduce processing times. Manufacturers who engage early with EDA requirements and maintain proactive communication with the authority consistently achieve faster review outcomes. Non-compliance with EDA post-market obligations, including vigilance reporting and renewal deadlines, can result in registration suspension.
Egypt's national health insurance expansion under the Universal Health Insurance Law and the government's hospital infrastructure investment program are driving sustained demand for imported and locally manufactured medical devices across diagnostic imaging, surgical instruments, in-vitro diagnostics, and patient monitoring categories. Public procurement through the Central Agency for Government Purchases represents a significant revenue channel for registered device manufacturers.
Egypt currently imports a large proportion of its medical device needs, with the European Union, United States, China, and Germany among the leading supplier countries. The government has introduced incentives to encourage local manufacturing and technology transfer partnerships, creating opportunities for foreign manufacturers who establish local production or assembly agreements. Devices manufactured locally still require EDA registration and must meet the same technical standards as imported products.
Every Taevas Global Product Registration engagement for Egypt Medical Devices delivers eight concrete outputs that move your device from regulatory assessment to active EDA registration.
A written assessment of your device's EDA classification, applicable registration pathway, and estimated timeline, giving leadership a clear picture of the regulatory journey ahead.
A fully compiled and internally audited technical dossier meeting EDA's current submission requirements for your device class, ready for portal upload.
A structured comparison of your existing technical documentation against EDA and ESO requirements, with a remediation plan for any identified gaps.
Professional review and preparation of Arabic-language device labeling and Instructions for Use in compliance with EDA labeling regulations.
Identification and due diligence assessment of qualified Egyptian local agents, with support for appointment documentation and EDA agent registration.
Preparation and submission of substantive responses to all EDA technical queries during the review period, with bilingual drafting and review by our in-country team.
Delivery of the official EDA registration certificate alongside a plain-language summary of registration conditions, commitments, and ongoing obligations.
A practical guide covering renewal timelines, variation filing triggers, post-market surveillance requirements, and EDA vigilance reporting obligations for your registered device.
Your device is approved in the EU or US and you are ready to expand into the Middle East and Africa region, with Egypt as a priority market. You need a regulatory partner who understands EDA's requirements, can manage the local agent setup, and will handle the full submission process without burdening your internal team. Speed and certainty are your top priorities.
Taevas Global's in-country regulatory team is ready to assess your device, map your EDA registration pathway, and manage the full submission process so you can focus on building your Egypt commercial strategy.